213 related articles for article (PubMed ID: 14663776)
1. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.
Rugo HS; Ahles T
Semin Oncol; 2003 Dec; 30(6):749-62. PubMed ID: 14663776
[TBL] [Abstract][Full Text] [Related]
2. Cognitive Deficits in Breast Cancer Survivors After Chemotherapy and Hormonal Therapy.
Frank JS; Vance DE; Triebel KL; Meneses KM
J Neurosci Nurs; 2015 Dec; 47(6):302-12. PubMed ID: 26447567
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
[TBL] [Abstract][Full Text] [Related]
4. Cognitive side-effects of adjuvant treatments.
Burstein HJ
Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
[TBL] [Abstract][Full Text] [Related]
5. Brain vulnerability to chemotherapy toxicities.
Ahles TA
Psychooncology; 2012 Nov; 21(11):1141-8. PubMed ID: 23023994
[TBL] [Abstract][Full Text] [Related]
6. Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy.
O'Shaughnessy JA
Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S116-20. PubMed ID: 12533272
[TBL] [Abstract][Full Text] [Related]
7. Post-treatment Neurocognition and Psychosocial Care Among Breast Cancer Survivors.
Buchanan ND; Dasari S; Rodriguez JL; Lee Smith J; Hodgson ME; Weinberg CR; Sandler DP
Am J Prev Med; 2015 Dec; 49(6 Suppl 5):S498-508. PubMed ID: 26590645
[TBL] [Abstract][Full Text] [Related]
8. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions.
Phillips KA; Bernhard J
J Natl Cancer Inst; 2003 Feb; 95(3):190-7. PubMed ID: 12569140
[TBL] [Abstract][Full Text] [Related]
10. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
[No Abstract] [Full Text] [Related]
12. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
13. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
[TBL] [Abstract][Full Text] [Related]
14. Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?
Buwalda B; Schagen SB
Life Sci; 2013 Oct; 93(17):581-8. PubMed ID: 23353876
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for breast cancer and cognitive impairment.
Marín AP; Sánchez AR; Arranz EE; Auñón PZ; Barón MG
South Med J; 2009 Sep; 102(9):929-34. PubMed ID: 19668023
[TBL] [Abstract][Full Text] [Related]
16. Cognitive functioning in breast cancer survivors: a controlled comparison.
Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.
Hermelink K
J Natl Cancer Inst Monogr; 2015 May; 2015(51):67-9. PubMed ID: 26063891
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
19. Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol.
Dwek MR; Rixon L; Simon A; Hurt C; Newman S
BMC Psychol; 2015 Nov; 3():43. PubMed ID: 26612628
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer chemotherapy-related cognitive dysfunction.
Ahles TA; Saykin AJ
Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S84-90. PubMed ID: 12533268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
